vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.
Sprout Social, Inc. is the larger business by last-quarter revenue ($120.9M vs $83.5M, roughly 1.4× BillionToOne, Inc.). On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 12.9%). Sprout Social, Inc. produced more free cash flow last quarter ($9.9M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.
BLLN vs SPT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $120.9M |
| Net Profit | $5.7M | — |
| Gross Margin | 69.9% | 77.6% |
| Operating Margin | 11.5% | -9.0% |
| Net Margin | 6.8% | — |
| Revenue YoY | 117.4% | 12.9% |
| Net Profit YoY | 138.3% | — |
| EPS (diluted) | $0.10 | $-0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $120.9M | ||
| Q3 25 | $83.5M | $115.6M | ||
| Q2 25 | — | $111.8M | ||
| Q1 25 | — | $109.3M | ||
| Q4 24 | — | $107.1M | ||
| Q3 24 | $38.4M | $102.6M | ||
| Q2 24 | — | $99.4M | ||
| Q1 24 | — | $96.8M |
| Q4 25 | — | — | ||
| Q3 25 | $5.7M | $-9.4M | ||
| Q2 25 | — | $-12.0M | ||
| Q1 25 | — | $-11.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-14.9M | $-17.1M | ||
| Q2 24 | — | $-16.9M | ||
| Q1 24 | — | $-13.6M |
| Q4 25 | — | 77.6% | ||
| Q3 25 | 69.9% | 77.7% | ||
| Q2 25 | — | 77.7% | ||
| Q1 25 | — | 77.3% | ||
| Q4 24 | — | 78.1% | ||
| Q3 24 | 52.6% | 77.4% | ||
| Q2 24 | — | 77.5% | ||
| Q1 24 | — | 76.8% |
| Q4 25 | — | -9.0% | ||
| Q3 25 | 11.5% | -7.9% | ||
| Q2 25 | — | -11.0% | ||
| Q1 25 | — | -10.2% | ||
| Q4 24 | — | -12.8% | ||
| Q3 24 | -32.9% | -16.4% | ||
| Q2 24 | — | -16.6% | ||
| Q1 24 | — | -13.7% |
| Q4 25 | — | — | ||
| Q3 25 | 6.8% | -8.1% | ||
| Q2 25 | — | -10.7% | ||
| Q1 25 | — | -10.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -38.8% | -16.6% | ||
| Q2 24 | — | -17.0% | ||
| Q1 24 | — | -14.0% |
| Q4 25 | — | $-0.18 | ||
| Q3 25 | $0.10 | $-0.16 | ||
| Q2 25 | — | $-0.21 | ||
| Q1 25 | — | $-0.19 | ||
| Q4 24 | — | $-0.25 | ||
| Q3 24 | $-1.47 | $-0.30 | ||
| Q2 24 | — | $-0.30 | ||
| Q1 24 | — | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $95.3M |
| Total DebtLower is stronger | $55.0M | $40.0M |
| Stockholders' EquityBook value | $-239.5M | $203.4M |
| Total Assets | $327.5M | $523.1M |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $95.3M | ||
| Q3 25 | $195.2M | $90.6M | ||
| Q2 25 | — | $101.5M | ||
| Q1 25 | — | $100.9M | ||
| Q4 24 | — | $86.4M | ||
| Q3 24 | — | $82.9M | ||
| Q2 24 | — | $80.9M | ||
| Q1 24 | — | $69.2M |
| Q4 25 | — | $40.0M | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $25.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $203.4M | ||
| Q3 25 | $-239.5M | $194.1M | ||
| Q2 25 | — | $184.6M | ||
| Q1 25 | — | $175.3M | ||
| Q4 24 | — | $166.6M | ||
| Q3 24 | $-242.9M | $158.1M | ||
| Q2 24 | — | $152.1M | ||
| Q1 24 | — | $147.3M |
| Q4 25 | — | $523.1M | ||
| Q3 25 | $327.5M | $481.4M | ||
| Q2 25 | — | $422.9M | ||
| Q1 25 | — | $424.7M | ||
| Q4 24 | — | $428.3M | ||
| Q3 24 | — | $388.8M | ||
| Q2 24 | — | $393.6M | ||
| Q1 24 | — | $389.9M |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $10.9M |
| Free Cash FlowOCF − Capex | $6.5M | $9.9M |
| FCF MarginFCF / Revenue | 7.7% | 8.2% |
| Capex IntensityCapex / Revenue | 8.8% | 0.9% |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $39.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.9M | ||
| Q3 25 | $13.8M | $9.3M | ||
| Q2 25 | — | $5.1M | ||
| Q1 25 | — | $18.1M | ||
| Q4 24 | — | $4.1M | ||
| Q3 24 | — | $9.0M | ||
| Q2 24 | — | $2.1M | ||
| Q1 24 | — | $11.2M |
| Q4 25 | — | $9.9M | ||
| Q3 25 | $6.5M | $8.5M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | — | $16.7M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $8.5M | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | — | $10.1M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | 7.7% | 7.4% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 15.3% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 10.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 8.8% | 0.7% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
SPT
Segment breakdown not available.
